Nichias (TSE:5393) is planning to build a plant in Taiwan to produce key chipmaking tubes, according to Nikkei. This development is drawing fresh attention to how the move could influence the stock’s semiconductor exposure.
Over the past year Nichias has attracted fresh interest from investors, with the share price delivering a year to date return of 48.07% and a 1 year total shareholder return of 85.20%. The 3 year total shareholder return of 261.00% and 5 year total shareholder return of 315.31% point to strong long term compounding. In the shorter term, a 4.24% 7 day share price return and 4.72% 30 day share price return show that momentum has picked up again after the share price declined 3.29% over 90 days. The Taiwan chipmaking project gives the market a fresh focal point for reassessing growth potential and risk around its semiconductor exposure.
Scan other industrials benefiting from similar semiconductor demand shifts with a curated set of 55 AI infrastructure stocks alongside Nichias.
Nichias now trades around a 20% discount to the average analyst price target, yet its own intrinsic value estimate signals a premium. After the Taiwan chipmaking move and the recent share price surge, is the market’s caution misplaced or prudent?
Preferred P/E of 19.3x for Nichias: Is it justified?
On a simple snapshot, Nichias trades on a P/E of 19.3x, which looks moderate against some peers but richer once you compare it with both its industry and a fair value benchmark.
The P/E ratio compares the current share price to earnings per share. For a manufacturer like Nichias, with established businesses in insulation materials, fluororesin products and components for sectors such as semiconductors and construction, P/E gives a quick read on how much investors are paying for each unit of current earnings.
According to the checks provided, Nichias is considered good value when lined up against its peer group average P/E of 33.4x. That suggests the market is not applying the same earnings premium some similar companies receive, even though Nichias has grown earnings by 13.1% per year over the past 5 years and reports what is described as high quality earnings. At the same time, the company’s earnings are forecast to grow 5.7% per year, which is slower than the wider JP market forecast of 8.9% per year. Part of this discount relative to peers may reflect more measured profit expectations.
The comparison shifts once you bring in the industry and the estimated fair ratio. Nichias trades on a 19.3x P/E versus 13x for the JP Building industry average, which points to a clear premium in its home sector. When set against an estimated fair P/E of 17.3x, the current 19.3x multiple sits above the level the market could move towards if pricing aligned more closely with that fair ratio anchor.
Explore the SWS fair ratio for Nichias.
Result: Price-to-Earnings of 19.3x (OVERVALUED)
However, Nichias still faces clear risks if Taiwan plant costs rise faster than expected or if semiconductor demand softens, which could pressure earnings and sentiment.
Find out about the key risks to this Nichias narrative.
Another View on Nichias Using the SWS DCF Model
The SWS DCF model tells a different story for Nichias. On this view, the estimated future cash flow value is ¥2,728.25 per share, while the current price is ¥3,415. That points to the stock trading at a premium rather than a discount. Which signal do you trust more: earnings multiple or cash flows?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Nichias for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 26 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
With sentiment around Nichias now mixed between growth hopes and valuation concerns, it may be helpful to act promptly and weigh the evidence for yourself. Start by reviewing the 4 key rewards
Looking for more investment ideas beyond Nichias?
If Nichias has your attention, do not stop there. Use the Simply Wall Street screener to compare it with other stocks that might suit your goals.
- Tap into potential mispricings by reviewing a curated set of 26 high quality undervalued stocks that may warrant a closer look beside Nichias.
- Strengthen your focus on resilience by scanning a list of solid balance sheet and fundamentals (41 results) and see which businesses match your comfort with financial stability.
- Stay early to new stories by checking a carefully filtered group of 74 high quality undiscovered gems before the wider market pays attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com